Restricted Drug Distribution Programs (Mod 7 Doc)

Question 1

Clozapine (clozaril)

Answer 1

Treats Schizophrenia

Concern is that the patient may become anemic

Prescriber must provide results of white blood cell count to pharmacy before dispensing

Question 2

Tikosyn

Answer 2

Treats irregular heartbeats

Concern is that patients with long QT syndromes may become more arrhythmic

Requires pharmacy to enroll in T.I.P.S. program (Tikosyn in Pharmacy System) before dispensing or ordering from wholesaler

Question 3

Promacta

Answer 3

Prevents bleeding in those with certain medical conditions

Concern is for Hematological Malignancy

Requires form submission to PromactaCares program before dispensing and providing a guide to the patient with every prescription dispensed

Question 4

Abstral

Answer 4

Treats breakthrough pain, as of Jan 11, approved for patients with cancer pain

CII- Concern is for overuse, respiratory depression

Requires pharmacy to obtain Abstral only through authorized distributors

Requires enrollment in Abstral REMS program

Question 5

Accutane

Answer 5

Treats severe acne

Concern is for fetal malformations

Enrollment in IPLEDGE, monthly verification of two negative pregnancy tests, patient must use two forms of contraceptive

Question 6

Revlimid

Answer 6

Treats a condition where bone marrow produces misshapen unhealthy blood cells

Concern is for fetal malformations

Enrollment in RevAssist, monthly verification of negative pregnancy test, patient must use two forms of contraceptive

Question 7

Thalomid

Answer 7

Prevents bleeding in those with certain medical conditions

Concern is for fetal malformations

Enrollment to S.T.E.P.S., pharmacy must call program before dispensing

Question 8

Zyprexa Relprew

Answer 8

Treats schizophrenia

CII- Concern is for Post-Injection Delirium/ Sedation Syndrome

Requires enrollment in Zyprexa Relprew Patient Care Program